129 related articles for article (PubMed ID: 37788806)
1. Percutaneous ablation of colorectal liver metastases: a comparison between the outcomes of grayscale US guidance and Sonazoid CEUS Kupffer phase guidance using propensity score matching.
Qin S; Zhou J; Cui R; Chen Y; Wang Y; Liu G
Int J Hyperthermia; 2023; 40(1):2260573. PubMed ID: 37788806
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
Lee Y; Yoon JH; Han S; Joo I; Lee JM
Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
[TBL] [Abstract][Full Text] [Related]
3. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
[TBL] [Abstract][Full Text] [Related]
4. Role of contrast-enhanced ultrasound with Perfluorobutane in lesion detection, guidance for microwave ablation, and response assessment of hepatocellular carcinoma.
Mukund A; Bansal A; Patidar Y; Thapar S; Sharma MK; Sarin SK
Abdom Radiol (NY); 2022 Oct; 47(10):3459-3467. PubMed ID: 35842563
[TBL] [Abstract][Full Text] [Related]
5. Role of Sonazoid enhanced ultrasound assistant laparoscopic radiofrequency ablation in treating liver malignancy-A single-center retrospective cohort study.
Xu J; Liu Y; Wu M; Song J; Li C
Cancer Med; 2023 Apr; 12(8):9075-9084. PubMed ID: 36880113
[TBL] [Abstract][Full Text] [Related]
6. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
7. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
Du J; Li HL; Zhai B; Chang S; Li FH
Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
[TBL] [Abstract][Full Text] [Related]
9. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
[TBL] [Abstract][Full Text] [Related]
10. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
[TBL] [Abstract][Full Text] [Related]
11. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.
Zheng SG; Xu HX; Lu MD; Xie XY; Xu ZF; Liu GJ; Liu LN
World J Gastroenterol; 2013 Feb; 19(6):855-65. PubMed ID: 23430451
[TBL] [Abstract][Full Text] [Related]
12. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
[TBL] [Abstract][Full Text] [Related]
13. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
14. Thermal ablation of medium-sized hepatocellular carcinomas using intraoperative ultrasound fusion imaging: A propensity score-matched analysis.
Luo L; He X; Li K; Long Y; Zeng Q; Tan L; Zheng R; Xu E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101581. PubMed ID: 33761441
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.
Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B
Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score matching analysis.
Jin T; Liu X; Zhang H; Cao Y; Dai C; Tang S; Xu F
Int J Hyperthermia; 2020; 37(1):955-964. PubMed ID: 32781862
[TBL] [Abstract][Full Text] [Related]
17. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
[TBL] [Abstract][Full Text] [Related]
18. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study of Application of Computed Tomography/Ultrasound and Computed Tomography Imaging Guidance Methods in the Microwave Ablation of Liver Cancer.
Liang J; Zhang S; Han Z; Li Y; Sun H; Kim Y; Kim T
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):24-30. PubMed ID: 36055224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
